Simplex Trading
AQST icon

Simplex Trading’s Aquestive Therapeutics AQST Stock Holding History

Simplex Trading’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$786K Sell
189,400
-46,900
-20% -$190K ﹤0.01% 2743
2025
Q4 		$1.53M Buy
236,300
+27,300
+13% +$170K ﹤0.01% 2206
2025
Q3 		$1.17M Buy
209,000
+153,600
+277% +$664K ﹤0.01% 2897
2025
Q2 		$183K Buy
55,400
+50,800
+1,104% +$146K ﹤0.01% 4599
2025
Q1 		$13K Sell
4,600
-15,600
-77% -$47.2K ﹤0.01% 6881
2024
Q4 		$71K Sell
20,200
-64,700
-76% -$298K ﹤0.01% 5497
2024
Q3 		$422K Sell
84,900
-71,700
-46% -$279K ﹤0.01% 3779
2024
Q2 		$407K Buy
156,600
+60,300
+63% +$201K ﹤0.01% 3866
2024
Q1 		$410K Buy
96,300
+87,100
+947% +$290K ﹤0.01% 4048
2023
Q4 		$18K Sell
9,200
-6,800
-43% -$12K ﹤0.01% 6982
2023
Q3 		$24K Buy
16,000
+13,400
+515% +$23K ﹤0.01% 6456
2023
Q2 		$4K Buy
+2,600
New +$4.7K ﹤0.01% 7999
2023
Q1 		– Sell
-8,400
Closed -$7K – 8943
2022
Q4 		$7K Sell
8,400
-2,400
-22% -$2.25K ﹤0.01% 7792
2022
Q3 		$12K Buy
+10,800
New +$12.2K ﹤0.01% 8039
2022
Q2 		– Sell
-17,100
Closed -$44K – 9879
2022
Q1 		$44K Sell
17,100
-54,200
-76% -$158K ﹤0.01% 7298
2021
Q4 		$277K Buy
71,300
+27,900
+64% +$140K ﹤0.01% 4686
2021
Q3 		$169K Hold
43,400
– – ﹤0.01% 5854
2021
Q2 		$172K Buy
43,400
+42,787
+6,980% +$171K ﹤0.01% 5923
2021
Q1 		$318K Buy
613
+329
+116% +$1.75K ﹤0.01% 4078
2020
Q4 		$151K Buy
284
+163
+135% +$977 ﹤0.01% 4973
2020
Q3 		$58K Buy
121
+101
+505% +$660 ﹤0.01% 5461
2020
Q2 		$9K Buy
+20
New +$92 ﹤0.01% 6694

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Simplex Trading's AQST Position: Q4 2025 in Review

Simplex Trading sold out of Aquestive Therapeutics (AQST) in Q4 2025, closing a stake of 51,177 shares — an estimated $319K sold.

Simplex Trading first reported a position in AQST in Q1 2020 and held it in 13 quarters. The position peaked at $343K in Q4 2021. 176 funds tracked by Wall St. Rank hold AQST as of Q4 2025.

  • Simplex Trading reported no remaining Aquestive Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Simplex Trading sold 51,177 Aquestive Therapeutics shares in Q4 2025, an estimated $319K.
  • Simplex Trading first reported a position in Aquestive Therapeutics in Q1 2020 and held it in 13 quarters.
  • Simplex Trading's Aquestive Therapeutics position peaked at $343K in Q4 2021.
  • 176 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q4 2025.

Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.